SAB Biotherapeutics (SABS) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
SAB Biotherapeutics (SABS) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 0.15 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -0.06 |
| 10 | SAB Biotherapeutics | 296.68 Mn | 296.68 Mn | - | -0.28 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.28 |
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -0.25 |
| Sep 30, 2025 | -0.15 |
| Jun 30, 2025 | -1.09 |
| Mar 31, 2025 | -0.56 |
| Dec 31, 2024 | -1.23 |
| Sep 30, 2024 | -1.12 |
| Jun 30, 2024 | -0.79 |
| Mar 31, 2024 | -0.54 |
| Dec 31, 2023 | -4.14 |
| Sep 30, 2023 | -0.97 |
| Jun 30, 2023 | -1.36 |
| Mar 31, 2023 | -1.46 |
| Dec 31, 2022 | -1.81 |
| Sep 30, 2022 | -1.64 |
| Jun 30, 2022 | -1.11 |
| Mar 31, 2022 | 0.22 |
| Dec 31, 2021 | -4.23 |
| Sep 30, 2021 | -1.56 |